相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Systematic review with meta-analysis: malignancies with anti-tumour necrosis factor-α therapy in inflammatory bowel disease
C. J. M. Williams et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Four-Year Maintenance Treatment With Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Data from ULTRA 1, 2, and 3
Jean-Frederic Colombel et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Demyelinizing neurological disease after treatment with tumor necrosis factor alpha-inhibiting agents in a rheumatological outpatient clinic: description of six cases
Ali Theibich et al.
CLINICAL RHEUMATOLOGY (2014)
Hepatotoxicity Caused by Methotrexate Therapy in Children with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
Pamela L. Valentino et al.
INFLAMMATORY BOWEL DISEASES (2014)
Long-term Safety and Tolerability of Once-daily Mesalamine Granules in the Maintenance of Remission of Ulcerative Colitis
Gary R. Lichtenstein et al.
INFLAMMATORY BOWEL DISEASES (2014)
Inflammation and disease duration have a cumulative effect on the risk of dysplasia and carcinoma in IBD: A case-control observational study based on registry data
Urpo Nieminen et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Colorectal cancer in inflammatory bowel disease: Results of the 3rd ECCO pathogenesis scientific workshop (I)
Shaji Sebastian et al.
JOURNAL OF CROHNS & COLITIS (2014)
Systematic review: Histological remission in inflammatory bowel disease. Is 'complete' remission the new treatment paradigm? An IOIBD initiative
R. V. Bryant et al.
JOURNAL OF CROHNS & COLITIS (2014)
Frequency and prognostic role of mucosal healing in patients with Crohn's disease and ulcerative colitis after one-year of biological therapy
Klaudia Farkas et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Critical Review of the Evidence on 5-Aminosalicilate for Chemoprevention of Colorectal Cancer in Ulcerative Colitis: A Methodological Question
Giovanna Margagnoni et al.
CURRENT CLINICAL PHARMACOLOGY (2014)
Methotrexate for maintenance of remission in Crohn's disease
Vishal Patel et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Predictors of relapse in patients with Crohn's disease in remission after 1 year of biological therapy
T. Molnar et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Inflammation Is an Independent Risk Factor for Colonic Neoplasia in Patients With Ulcerative Colitis: A Case-Control Study
David T. Rubin et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Definition and evaluation of mucosal healing in clinical practice
Silvia Mazzuoli et al.
DIGESTIVE AND LIVER DISEASE (2013)
Risk of Lymphoma in Patients With Ulcerative Colitis Treated With Thiopurines: A Nationwide Retrospective Cohort Study
Nabeel Khan et al.
GASTROENTEROLOGY (2013)
Predictors of relapse in patients with ulcerative colitis in remission after one-year of infliximab therapy
Klaudia Farkas et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2013)
Thiopurines in inflammatory bowel disease revisited
Florian Baer et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Clinical Remission After Stopping Infliximab in Crohn's Disease: Is All That Glitters True Gold?
Dario Sorrentino et al.
GASTROENTEROLOGY (2012)
Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped
Edouard Louis et al.
GASTROENTEROLOGY (2012)
Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
William J. Sandborn et al.
GASTROENTEROLOGY (2012)
Incidence of liver toxicity in inflammatory bowel disease patients treated with methotrexate: A meta-analysis of clinical trials
Nabeel Khan et al.
INFLAMMATORY BOWEL DISEASES (2012)
Postoperative recurrent luminal Crohn's Disease: A systematic review
Peter De Cruz et al.
INFLAMMATORY BOWEL DISEASES (2012)
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
Axel Dignass et al.
JOURNAL OF CROHNS & COLITIS (2012)
Outcome after discontinuation of infliximab in patients with inflammatory bowel disease in clinical remission: an observational Danish single center study
Casper Steenholdt et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
Crohn's disease genotypes of patients in remission vs relapses after infliximab discontinuation
Cathy Lu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Mesalamine in the treatment and maintenance of remission of ulcerative colitis
Maggie Ham et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2012)
Every fourth patient with Crohn's disease has anti-TNF dependency
T. Molnar et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
The Risk of Inflammatory Bowel Disease-Related Colorectal Carcinoma Is Limited: Results From a Nationwide Nested Case-Control Study
Judith E. Baars et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Medical management of inflammatory bowel disease among Canadian gastroenterologists
J. Jones et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Methotrexate in ulcerative colitis: A Spanish multicentric study on clinical use and efficacy
Miriam Manosa et al.
JOURNAL OF CROHNS & COLITIS (2011)
Maintenance of clinical benefit in Crohn's disease patients after discontinuation of infliximab: long-term follow-up of a single centre cohort
A. W. G. Waugh et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Increased Risk for Non-Melanoma Skin Cancer in Patients With Inflammatory Bowel Disease
Millie D. Long et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
A. Dignass et al.
JOURNAL OF CROHNS & COLITIS (2010)
Review: Current trends in inflammatory bowel disease: the natural history
Ebbe Langholz
Therapeutic Advances in Gastroenterology (2010)
Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis
J. P. Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Maintenance Treatment With Azathioprine in Ulcerative Colitis: Outcome and Predictive Factors After Drug Withdrawal
Andrea Cassinotti et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Loss of Response and Requirement of Infliximab Dose Intensification in Crohn's Disease: A Review
Javier P. Gisbert et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Azathioprine Withdrawal in Patients With Crohn's Disease Maintained on Prolonged Remission: A High Risk of Relapse
Xavier Treton et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study
H. Fidder et al.
GUT (2009)
Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort
F. Schnitzler et al.
GUT (2009)
Lack of Association Between Cervical Dysplasia and IBD: A Large Case-Control Study
C. W. Lees et al.
INFLAMMATORY BOWEL DISEASES (2009)
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
Laurent Beaugerie et al.
LANCET (2009)
Reactive oxygen species generated by thiopurine/UVA cause irreparable transcription-blocking DNA lesions
Reto Brem et al.
NUCLEIC ACIDS RESEARCH (2009)
Duration of remission and long-term prognosis according to the extent of disease in patients with ulcerative colitis on continuous mesalamine treatment
G. Bresci et al.
COLORECTAL DISEASE (2008)
Risk factors for opportunistic infections in patients with inflammatory bowel disease
Murat Toruner et al.
GASTROENTEROLOGY (2008)
How Long Is It Advisable to Prolong Maintenance Treatment of Patients with Ulcerative Colitis?
Sandro Ardizzone et al.
INFLAMMATORY BOWEL DISEASES (2008)
Long-term outcome after infliximab for refractory ulcerative colitis
Marc Ferrante et al.
JOURNAL OF CROHNS & COLITIS (2008)
Maintenance of remission with infliximab in inflammatory bowel disease: Efficacy and safety long-term follow-up
Renato Caviglia et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial
W. J. Sandborn et al.
GUT (2007)
The long-term efficacy of azathioprine does not wane after four years of continuous treatment in patients with steroid-dependent luminal Crohn's disease
Gerassimos J. Mantzaris et al.
JOURNAL OF CROHNS & COLITIS (2007)
Duration of treatment with 5-aminosalicylic acid compounds
T. Moshkovska et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Meta-analysis of risk of malignancy with immunosuppressive drugs in inflammatory bowel disease
Yukari Masunaga et al.
ANNALS OF PHARMACOTHERAPY (2007)
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial
Jean-Frederic Colombel et al.
GASTROENTEROLOGY (2007)
The risks and the benefits of mesalazine as a treatment for ulcerative colitis
Alan C. Moss et al.
EXPERT OPINION ON DRUG SAFETY (2007)
Long-term effectiveness of azathioprine in IBD beyond 4 years:: A European multicenter study in 1176 patients
Martin H. Holtmann et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry
GR Lichtenstein et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease
C Canavan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Risk of intestinal cancer in inflammatory bowel disease: A population-based study from Olmsted County, Minnesota
T Jess et al.
GASTROENTEROLOGY (2006)
Clinical evolution of luminal and perianal Crohn's disease after inducing remission with infliximab:: how long should patients be treated?
E Domènech et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine
A Kandiel et al.
GUT (2005)
A randomized, douuble-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine
M Lémann et al.
GASTROENTEROLOGY (2005)
6-Tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine
X Roblin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
High Incidence of Anergy in Inflammatory Bowel Disease Patients Limits the Usefulness of PPD Screening Before Infliximab Therapy
William S. Mow et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
Systematic review: short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis
EV Loftus et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Long-term Risk of Cancer in Ulcerative Colitis: A Population-Based Cohort Study From Copenhagen County
Karen V. Winther et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
Randomized controlled azathioprine withdrawal after more than two years treatment in Crohn's disease:: increased relapse rate the following year
M Vilien et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Methotrexate: first-line or second-line immunomodulator?
AG Fraser
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2003)
Lesson of the week - Low dose methotrexate and bone marrow suppression
M Sosin et al.
BRITISH MEDICAL JOURNAL (2003)
The efficacy of methotrexate for maintaining remission in inflammatory bowel disease
AG Fraser et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review
AG Fraser et al.
GUT (2002)
分享论文
